Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Asti

8 clinical trials in Asti, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Asti at a glance
8
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

8 trials in Asti

Open in trial search

Study on the Effects of Tumor Removal in Patients with Metastatic Kidney Cancer Treated with Nivolumab and Ipilimumab Combination

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Axitinib
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Study on the Effects of Ticagrelor and Rivaroxaban in Patients with Atrial Fibrillation After Coronary Stent Surgery

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Insel Gruppe AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Azienda USL IRCCS Di Reggio Emilia

Osimertinib and drug combination in metastatic non‑small cell lung cancer with targetable genomic driver alterations

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Universita' Degli Studi Di Torino
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Ospedale San Raffaele S.r.l.

Study of BI 690517 and empagliflozin combination for protection of heart and kidneys in patients with chronic kidney disease

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study of luxdegalutamide and abiraterone combination in adult men with metastatic hormone-sensitive prostate cancer

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:Novartis Pharma AG

Lung disorder

Not recruiting

Study on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19

Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Oslo University Hospital HF

Other cities in Italy

The busiest research cities in the country

All 237 cities in Italy

Clinical research in Asti

What the registry says about research in the country

01 Oncology Research

Clinical investigations focusing on metastatic renal cell carcinoma and innovative immunotherapy approaches, evaluating the impact of primary tumor treatments on patient outcomes.

  • Renal Cell Carcinoma
  • Urothelial Cancer
  • Metastatic Colorectal Cancer

Novel therapeutic combinations and targeted treatments are being explored for various cancer types.

02 Cardiovascular Studies

Research examining anticoagulation strategies in patients with atrial fibrillation who have undergone coronary interventions, focusing on optimizing blood clot prevention protocols.

  • Post-PCI Treatment
  • Antithrombotic Therapy
  • Cardiac Safety

Evaluating innovative approaches to reduce bleeding risks while maintaining therapeutic efficacy.

03 Women's Health

Investigating treatment options for recurrent ovarian cancer, specifically examining the effectiveness of combination therapies with pegylated liposomal doxorubicin and trabectedin.

  • Ovarian Cancer Treatment
  • Drug Rechallenge Studies
  • Therapeutic Combinations

Focus on developing treatment strategies for patients with limited therapeutic options.

04 Infectious Diseases

Conducting adaptive platform trials for COVID-19 treatment, evaluating therapeutic interventions for both moderate and severe disease cases.

  • COVID-19 Management
  • Emerging Infections
  • Immunocompromised Patients

Research aimed at improving outcomes in hospitalized patients with varying disease severity.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.